About SinoDrugWatch

SinoDrugWatch is an independent publication dedicated to tracking key developments in drug discovery, biotech innovation, and business strategy shaping China’s pharmaceutical landscape.

As global pharma companies confront patent cliffs and thinning pipelines, China has emerged as a vital hub for new assets, partnerships, and scientific breakthroughs. SinoDrugWatch delivers timely, curated insights into how domestic and multinational players are navigating this dynamic ecosystem — from early-stage discovery to cross-border deals and regulatory evolution.

We focus on concise, insight-driven summaries and analysis that cut through the noise — providing a trusted resource for professionals across R&D, business development, investment, and policy.

🔍 What You’ll Find Here

Curated Summaries
Essential biotech and pharma developments from China — analyzed and presented with global relevance.

Deal Tracking & Market Insights
Focused coverage of licensing deals, clinical pipelines, and emerging biotech trends.

China’s Role in Global Pharma
Exploring how Chinese innovation, partnerships, and regulation are reshaping the global industry.

Thank you for reading and supporting SinoDrugWatch.
We aim to be a trusted lens on China’s drug innovation boom — with clarity, independence, and focus.